doi:10.3969/j.issn.1673-8640.2024.08.015

Abstract

CLC Number:

R446.11

Figures/Tables 5

References 13

[1]	ANDREW M, PAES B, MILNER R, et al. Development of the human coagulation system in the healthy premature infant[J]. Blood, 1988, 72(5):1651-1657. PMID
[2]	LI J, LAI X, YAN C, et al. Age-associated developmental changes in the activated pratial thromboplastin time(APTT)and causes of prolonged APTT values in healthy Chinese children[J]. Clin Chem Lab Med, 2009, 47(12):1531-1537.
[3]	TRIPODI A, CHANTARANGKUL V. Lupus anticoagulant testing:activated partial thromboplastin time(APTT) and silica clotting time(SCT)[J]. Methods Mol Biol, 2017, 1646:177-183.
[4]	TOKUTAKE T, IEKO M, NAITO S, et al. Magnesium-dependent activated partial thromboplastin time assay-simple method for lupus anticoagulant detection[J]. Int J Lab Hematol, 2020, 42(1):46-51. DOI PMID
[5]	张家红, 王金行, 夏楠, 等. 活化部分凝血活酶时间检测狼疮抗凝物的灵敏度及其相关性[J]. 中国医科大学学报, 2021, 50(6):502-506.
[6]	李建新, 徐安平, 赖馨, 等. 儿童年龄相关的常规凝血功能检测指标参考区间调查[J]. 中华检验医学杂志, 2010, 33(12):1193-1195.
[7]	叶琴, 周芸, 张杰, 等. 南京地区未成年人群PT/INR和APTT参考区间的建立[J]. 临床检验杂志, 2016, 34(4):312-314.
[8]	CHRISTENSEN R D, BAER V L, LAMBERT D K, et al. Reference intervals for common coagulation tests of preterm infants(CME)[J]. Transfusion, 2014, 54(3):627-632.
[9]	NEARY E, NI AINLE F, COTTER M, et al. Coagulation values in extreme premature infants[J]. Transfusion, 2014, 54(8):2134. DOI PMID
[10]	迟林, 李爽, 尚欣荣, 等. 未成年人血浆PT、INR、APTT、FIB参考区间的初步建立[J]. 标记免疫分析与临床, 2021, 28(2):206-209.
[11]	郑建新, 郑昭璟, 杨慧, 等. 基于STA-Compact检测系统的儿童和青少年APTT和PT参考区间调查[J]. 检验医学, 2013, 28(9):762-764. DOI
[12]	程霞, 王卓, 杨丹, 等. 临床实验室APTT ACTIN FSL试剂建立活化部分凝血活酶时间参考范围[J]. 血栓与止血学, 2020, 26(4):579-581.
[13]	尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015.

组别	例数	PT/s	INR	APTT/s
1~10岁组	5 203	11.95±0.86	1.050±0.080	34.79±3.65
11~18岁组	5 291	12.30±1.09^#*	1.077±0.097^#*	33.39±3.62^#*
成人组	215	11.32±0.88^*	0.992±0.083^*	33.02±3.13^*
t值		13.86	12.67	9.45
P值		<0.000 1	<0.000 1	<0.000 1

组别	例数	PT/s	INR	APTT/s
1~10岁组	5 203	11.95±0.86	1.050±0.080	34.79±3.65
11~18岁组	5 291	12.30±1.09^#*	1.077±0.097^#*	33.39±3.62^#*
成人组	215	11.32±0.88^*	0.992±0.083^*	33.02±3.13^*
t值		13.86	12.67	9.45
P值		<0.000 1	<0.000 1	<0.000 1

项目	PT/s	INR	APTT/s
1~10岁组	10.26~13.64	0.89~1.21	27.64~41.94
11~18岁组	10.16~14.44	0.89~1.27	26.29~40.49
成人组	9.60~13.04	0.83~1.15	26.88~39.15
说明书参考区间	10.20~12.90	0.81~1.20	25.10~36.50

项目	PT/s	INR	APTT/s
1~10岁组	10.26~13.64	0.89~1.21	27.64~41.94
11~18岁组	10.16~14.44	0.89~1.27	26.29~40.49
成人组	9.60~13.04	0.83~1.15	26.88~39.15
说明书参考区间	10.20~12.90	0.81~1.20	25.10~36.50

[1]	DENG Shuang, FANG Jingshu, GAN Fangyan. Predictive value of activated partial thromboplastin time，thromboelastogram and fibrin monomer in patients treated with extracorporeal membrane oxygenation for hemorrhage and thrombosis [J]. Laboratory Medicine, 2024, 39(8): 764-769.
[2]	ZHANG Jialing, QI Jun. Interference and correction of chylemia on blood cell analysis parameters in tumor patients [J]. Laboratory Medicine, 2024, 39(8): 770-773.
[3]	WANG Tiankai, LIU Lin, JIN Peipei, WANG Fang, DING Ning. Clinical value of new neutrophil parameter NEU-X，NEU-Y and NEU-Z in diagnosis of sepsis [J]. Laboratory Medicine, 2024, 39(7): 682-686.
[4]	. [J]. Laboratory Medicine, 2024, 39(7): 696-699.
[5]	ZHAO Chunhe, SHAO Huihui, CUI Weiqi, XIA Wei, QU Linlin. Progress in application of blood coagulation point-of-care testing [J]. Laboratory Medicine, 2024, 39(7): 709-714.
[6]	. [J]. Laboratory Medicine, 2024, 39(6): 602-607.
[7]	ZHOU Ruiling, ZHANG Xinyu, REN Xiaoling, ZHANG Wen, FAN Changzheng, ZHANG Qiong. Relationship between uric acid/creatinine ratio and neutrophil/lymphocyte ratio and hypoxemia in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Laboratory Medicine, 2024, 39(5): 474-479.
[8]	LI Kejing, WANG Lin, YANG Ning. Relationship between NLR，TGF-β1 and Cav-1 levels and bleeding risk after mechanical thrombectomy for acute intracranial artery occlusion in elders [J]. Laboratory Medicine, 2024, 39(5): 480-484.
[9]	LIU Lin, WANG Tiankai, QIN Kangchunfeng, DING Ning. Correlations between monocyte-to-lymphocyte ratio with coronary heart disease and the extent of coronary atherosclerosis [J]. Laboratory Medicine, 2024, 39(5): 485-490.
[10]	WANG Xuexing, CHEN Chunmei, HE Yuan, CHU Jie, WEI Chunmei. Roles of thromboelastography and coagulation index in predicting venous thromboembolism in patients with tumors [J]. Laboratory Medicine, 2024, 39(5): 491-496.
[11]	XIONG Tianhui, CHAI Kening, XIA Wei, QU Linlin. Research progress of rivaroxaban causing changes in platelet count and function [J]. Laboratory Medicine, 2024, 39(5): 504-509.
[12]	. [J]. Laboratory Medicine, 2024, 39(5): 513-516.
[13]	HUANG Lei, TANG Wenjia, ZHOU Yan, ZHOU Jiaye, ZHANG Chunyan, YANG Jing, WANG Beili, PAN Baishen, GUO wei. Prognosis of RDW-SD and RDW-CV in breast cancer patients with lymphatic metastasis [J]. Laboratory Medicine, 2024, 39(4): 376-381.
[14]	. [J]. Laboratory Medicine, 2024, 39(1): 68-70.
[15]	DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 13

Related Articles 15

Recommended Articles

Metrics